A clinical nomogram predicting pathologic lymph node involvement in esophageal cancer patients
Puja Gaur1, Boris Sepesi, Wayne L Hofstetter
1Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.
Annals of Surgery
|October 1, 2010
Summary
This study developed a clinical nomogram to predict lymph node involvement in esophageal cancer patients before surgery. The nomogram accurately identifies high-risk individuals, aiding treatment decisions for better outcomes.
Area of Science:
- Oncology
- Surgical Oncology
- Gastroenterology
Background:
- Esophageal cancer with lymph node involvement (pN1) has a poor prognosis with surgery alone.
- Accurate prediction of pN1 pre-surgery is crucial for treatment planning.
Purpose of the Study:
- To construct and validate a nomogram predicting pN1 risk in esophageal adenocarcinoma patients before surgical resection.
- To assess the clinical utility of the predictive model.
Main Methods:
- Retrospective review of 273 esophageal adenocarcinoma patients from two institutions.
- Development of a nomogram using pretreatment clinical parameters (cT, cN, cL).
- Internal validation by bootstrapping and external validation on an independent cohort.
Main Results:
- Clinical tumor depth (cT) and clinical tumor length (cL) >2 cm were significant predictors of pN1.
- The nomogram achieved 85.1% accuracy in internal validation.
- External validation showed a C-index of 0.777, indicating good clinical utility.
Conclusions:
- A clinical nomogram can effectively estimate pN1 risk in esophageal adenocarcinoma.
- This tool aids in identifying high-risk patients for potential en bloc resection or neoadjuvant therapy.
- Improved risk stratification can lead to more personalized and effective treatment strategies.
